Name: UMIN ID:
Unique ID issued by UMIN | UMIN000000726 |
---|---|
Receipt number | R000000870 |
Scientific Title | Phase I/II trial of Amrubicin Hydrochloride in 3rd line treatment for patients with Recurrent Non-small cell Lung cancer [AMNOL-3rd] |
Date of disclosure of the study information | 2007/05/28 |
Last modified on | 2015/07/22 16:39:57 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2007/05/28 09:53:39 | ||
2 | Update | 2008/05/29 14:25:40 | Narrative objectives1 |
|
3 | Update | 2008/05/29 14:26:55 | Key inclusion criteria |
|
4 | Update | 2015/07/22 16:39:57 | Recruitment status |